CIK 0001824293 · <br>Emerging growth company
GRI Bio, Inc.
Sign in to watch- Ticker
- GRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824369909
- Phone
- (619) 400-1171
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 208, LA JOLLA, CA, 92037
- Former names
- Vallon Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-15 | Kelly Leanne M. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | $5.63 | $282K | 50,000 |
| 2021-06-04 | Kelly Leanne M. Chief Financial Officer | Purchase | +1,508 | $4.08 | $6K | 6,250 |
| 2021-06-03 | Kelly Leanne M. Chief Financial Officer | Purchase | +1,085 | $4.05 | $4K | 4,742 |
| 2021-06-02 | Kelly Leanne M. Chief Financial Officer | Purchase | +3,657 | $4.00 | $15K | 3,657 |
| 2021-05-26 | Payne Joseph E Director | Purchase | +6,800 | $4.50 | $31K | 17,500 |
| 2021-05-25 | Payne Joseph E Director | Purchase | +10,700 | $3.85 | $41K | 10,700 |
| 2021-05-14 | Payne Joseph E Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-05-14 | Payne Joseph E Director | Grant or award · Stock Option (Right to Buy) | +14,286 | 14,286 | ||
| 2021-05-14 | Ammer Richard Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-05-14 | Ammer Richard Director | Grant or award · Stock Option (Right to Buy) | +10,204 | 10,204 | ||
| 2021-05-14 | Levi Ofir Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-05-14 | Levi Ofir Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2021-05-14 | Kelly Leanne M. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2021-05-14 | Toren Penny SVP, Regul Affairs & Prog Mgmt | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-05-14 | Baker David Charles Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-02-12 | Ammer Richard Director | Other acquisition | +47,063 | $6.40 | $301K | 47,063 |
| 2021-02-12 | SALMON Pharma GmbH 10% owner | Other acquisition | +47,063 | $6.40 | $301K | 47,063 |
| 2021-02-12 | Thorell Marella Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-02-12 | Baker David Charles Chief Executive Officer | Other acquisition | +7,843 | $6.40 | $50K | 7,843 |
| 2021-02-12 | Baker David Charles Chief Executive Officer | Purchase | +1,000 | $8.00 | $8K | 8,843 |
Page 3 of 3 · 60 trades